[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370570-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370570-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","graphene-nanocomposites-in-the-targeting-tumor-microenvironment-recent-advances-in-tme-reprogramming","Graphene Nanocomposites in the Targeting Tumor Microenvironment - Recent Advances in TME Reprogramming","","Graphene-based materials offer significant promise in cancer therapy because of distinctive physicochemical properties, biocompatibility, and straightforward functionalization. They can target solid tumors, penetrate the tumor microenvironment (TME), and serve as efficient drug-delivery platforms in nanomedicine. The review addresses key barriers created by the complex, dynamic TME—metabolic heterogeneity, immune suppression, and drug resistance—by highlighting metabolic-pathway modulation. It emphasizes GBM functionalization with targeting ligands and biocompatible polymers to improve biosafety, specificity, and immune-cell interaction. It further explores metabolism-targeted strategies and combinations with immunotherapy to support more effective, personalized anticancer treatment via TME reprogramming.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/graphene-nanocomposites-in-the-targeting-tumor-microenvironment-recent-advances-in-tme-reprogramming/370570/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/graphene-nanocomposites-in-the-targeting-tumor-microenvironment-recent-advances-in-tme-reprogramming/370570.png","ImageObject",300,407,{"name":42,"@type":43},"Riley West","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are graphene-based materials promising for cancer therapy?","Question",{"text":63,"@type":64},"They combine unique physicochemical properties, biocompatibility, and ease of functionalization, enabling tumor targeting, TME penetration, and drug-delivery capabilities.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What challenges in the tumor microenvironment limit treatment effectiveness?",{"text":68,"@type":64},"The TME is complex and dynamic, showing metabolic heterogeneity, immune suppression, and drug resistance, which reduce therapeutic impact.",{"name":70,"@type":61,"acceptedAnswer":71},"How do functionalization strategies improve the performance of graphene nanocomposites?",{"text":72,"@type":64},"Attaching targeting ligands and biocompatible polymers enhances biosafety and specificity, improves solubility and stability, and supports improved immune-cell interactions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370570,1790404555,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":97,"preview_urls":146},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Review  \nGraphene Nanocomposites in the Targeting Tumor  \nMicroenvironment: Recent Advances in TME Reprogramming  \nArgiris Kolokithas-Ntoukas 1,2, Andreas Mouikis 1 and Athina Angelopoulou 1,3, *  \nAcademic Editor: Steven Fiering  \nReceived: 31 March 2025  \nRevised: 30 April 2025  \nAccepted: 6 May 2025  \nPublished: 9 May 2025  \nCitation: Kolokithas-Ntoukas, A.; Mouikis, A.; Angelopoulou, A. Graphene Nanocompositesin the Targeting Tumor Microenvironment:  \nRecent AdvancesinTMEReprogramming. Int. J. Mol. Sci. 2025, 26, 4525. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26104525  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Pharmacy, School of Health Sciences, University of Patras, GR-26504 Patras, Greece; [kolokithas@upatras.gr](kolokithas@upatras.gr) (A.K.-N.); [andreas27997@gmail.com](andreas27997@gmail.com) (A.M.)  \n2 Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute (CATRIN), Palacky University Olomouc, 779 00 Olomouc, Czech Republic  \n3 Metabolic Engineering and Systems Biology Laboratory, Institute of Chemical Engineering Sciences, Foundation for Research and Technology-Hellas (FORTH/ICE-HT), GR-26504 Patras, Greece  \n* Correspondence: [angelopoulou@upatras.gr or angelopoulouathina@gmail.com](angelopoulou@upatras.gr or angelopoulouathina@gmail.com)  \nAbstract: Graphene-based materials (GBMs) have shown significant promise in cancer therapy due to their unique physicochemical properties, biocompatibility, and ease of functionalization. Their ability to target solid tumors, penetrate the tumor microenvironment (TME), and act as efficient drug delivery platforms highlights their potential in nanomedicine. However, the complex and dynamic nature of the TME, characterized by metabolic heterogeneity, immune suppression, and drug resistance, poses significant challenges to effective cancer treatment. GBMs offer innovative solutions by enhancing tumor targeting, facilitating deep tissue penetration, and modulating metabolic pathways that contribute to tumor progression and immune evasion. Their functionalization with targeting ligands and biocompatible polymers improves their biosafety and specificity, while their ability to modulate immune cell interactions within the TME presents new opportunities for immunotherapy. Given the role of metabolic reprogramming in tumor survival and resistance, GBMs could be further exploited in metabolism-targeted therapies by disrupting glycolysis, mitochondrial respiration, and lipid metabolism to counteract the immunosuppressive effects of the TME. This review focuses on discussing research studies that design GBM nanocomposites with enhanced biodegradability, minimized toxicity, and improved efficacy in delivering therapeutic agents with the intention to reprogram the TME for effective anticancer therapy. Additionally, exploring the potential of GBM nanocomposites in combination with immunotherapies and metabolism-targeted treatments could lead to more effective and personalized cancer therapies. By addressing these challenges, GBMs could play a pivotal role in overcoming current limitations in cancer treatment and advancing precision oncology.  \nKeywords: graphene; nanomaterials; graphene oxide; cancer; photothermal therapy; photodynamic therapy  \n1. Introduction  \nGraphene (Gr) and graphene-based materials (GBMs), such as graphene oxide (GO) and reduced graphene oxide (rGO), have attracted considerable interest in biomedical research, especially for their application in targeting solid tumors, owing to their unique physicochemical characteristics, high surface area, and ease of functionalizatio","cbCaik8uCGGOilh4","https://ap.wps.com/l/cbCaik8uCGGOilh4","pdf",7445594,42,"English","# Introduction\n## Graphene-based materials for tumor targeting and theranostics\n## Toxicity variability and biosafety constraints\n## Functionalization strategies with polymers and ligands","[{\"question\":\"Why are graphene-based materials promising for cancer therapy?\",\"answer\":\"They combine unique physicochemical properties, biocompatibility, and ease of functionalization, enabling tumor targeting, TME penetration, and drug-delivery capabilities.\"},{\"question\":\"What challenges in the tumor microenvironment limit treatment effectiveness?\",\"answer\":\"The TME is complex and dynamic, showing metabolic heterogeneity, immune suppression, and drug resistance, which reduce therapeutic impact.\"},{\"question\":\"How do functionalization strategies improve the performance of graphene nanocomposites?\",\"answer\":\"Attaching targeting ligands and biocompatible polymers enhances biosafety and specificity, improves solubility and stability, and supports improved immune-cell interactions.\"}]","Graphene Nanocomposites in the Targeting Tumor Microenvironment - Recent Advances in TME Reprogramming | PDF",1790189233,106,[147,151,155,159,163],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ab586d26ed141400a60bc59d8c22ecc.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21fc6c5ae18140df437009aeeeb0b377.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d5b94fdcf6b6871008a1b50a9cd04b1.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f78d34f371ca6120310c0f0027e3212.webp",980,1385,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f146f0185d2661bebcb3c3674432a844.webp",979,1384]